Edesa Biotech, Inc.Edesa Biotech, Inc.Edesa Biotech, Inc.

Edesa Biotech, Inc.

No trades
See on Supercharts

EDSA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
EDSA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company